Literature DB >> 20445071

Noninvasive imaging of endogenous neural stem cell mobilization in vivo using positron emission tomography.

Maria Adele Rueger1, Heiko Backes, Maureen Walberer, Bernd Neumaier, Roland Ullrich, Marie-Lune Simard, Beata Emig, Gereon Rudolf Fink, Mathias Hoehn, Rudolf Graf, Michael Schroeter.   

Abstract

Neural stem cells reside in two major niches in the adult brain [i.e., the subventricular zone (SVZ) and the dentate gyrus of the hippocampus]. Insults to the brain such as cerebral ischemia result in a physiological mobilization of endogenous neural stem cells. Since recent studies showed that pharmacological stimulation can be used to expand the endogenous neural stem cell niche, hope has been raised to enhance the brain's own regenerative capacity. For the evaluation of such novel therapeutic approaches, longitudinal and intraindividual monitoring of the endogenous neural stem cell niche would be required. However, to date no conclusive imaging technique has been established. We used positron emission tomography (PET) and the radiotracer 3'-deoxy-3'-[(18)F]fluoro-l-thymidine ([(18)F]FLT) that enables imaging and measuring of proliferation to noninvasively detect endogenous neural stem cells in the normal and diseased adult rat brain in vivo. This method indeed visualized neural stem cell niches in the living rat brain, identified as increased [(18)F]FLT-binding in the SVZ and the hippocampus. Focal cerebral ischemia and subsequent damage of the blood-brain barrier did not interfere with the capability of [(18)F]FLT-PET to visualize neural stem cell mobilization. Moreover, [(18)F]FLT-PET allowed for an in vivo quantification of increased neural stem cell mobilization caused by pharmacological stimulation or by focal cerebral ischemia. The data suggest that noninvasive longitudinal monitoring and quantification of endogenous neural stem cell activation in the brain is feasible and that [(18)F]FLT-PET could be used to monitor the effects of drugs aimed at expanding the neural stem cell niche.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20445071      PMCID: PMC6632716          DOI: 10.1523/JNEUROSCI.6092-09.2010

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  43 in total

1.  Subventricular zone astrocytes are neural stem cells in the adult mammalian brain.

Authors:  F Doetsch; I Caillé; D A Lim; J M García-Verdugo; A Alvarez-Buylla
Journal:  Cell       Date:  1999-06-11       Impact factor: 41.582

Review 2.  The development of neural stem cells.

Authors:  S Temple
Journal:  Nature       Date:  2001-11-01       Impact factor: 49.962

3.  Regeneration of hippocampal pyramidal neurons after ischemic brain injury by recruitment of endogenous neural progenitors.

Authors:  Hirofumi Nakatomi; Toshihiko Kuriu; Shigeo Okabe; Shin-ichi Yamamoto; Osamu Hatano; Nobutaka Kawahara; Akira Tamura; Takaaki Kirino; Masato Nakafuku
Journal:  Cell       Date:  2002-08-23       Impact factor: 41.582

4.  Induction of neurogenesis in the neocortex of adult mice.

Authors:  S S Magavi; B R Leavitt; J D Macklis
Journal:  Nature       Date:  2000-06-22       Impact factor: 49.962

5.  Neurogenesis in dentate subgranular zone and rostral subventricular zone after focal cerebral ischemia in the rat.

Authors:  K Jin; M Minami; J Q Lan; X O Mao; S Batteur; R P Simon; D A Greenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

6.  Embryonic stem cell-derived glial precursors: a source of myelinating transplants.

Authors:  O Brüstle; K N Jones; R D Learish; K Karram; K Choudhary; O D Wiestler; I D Duncan; R D McKay
Journal:  Science       Date:  1999-07-30       Impact factor: 47.728

7.  Increased proliferation of neural progenitor cells but reduced survival of newborn cells in the contralateral hippocampus after focal cerebral ischemia in rats.

Authors:  Ken-ichiro Takasawa; Kazuo Kitagawa; Yoshiki Yagita; Tsutomu Sasaki; Shigeru Tanaka; Kohji Matsushita; Toshiho Ohstuki; Takaki Miyata; Hideyuki Okano; Masatsugu Hori; Masayasu Matsumoto
Journal:  J Cereb Blood Flow Metab       Date:  2002-03       Impact factor: 6.200

8.  Neuronal replacement from endogenous precursors in the adult brain after stroke.

Authors:  Andreas Arvidsson; Tove Collin; Deniz Kirik; Zaal Kokaia; Olle Lindvall
Journal:  Nat Med       Date:  2002-08-05       Impact factor: 53.440

9.  Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells.

Authors:  Janet S Rasey; John R Grierson; Linda W Wiens; Pamella D Kolb; Jeffrey L Schwartz
Journal:  J Nucl Med       Date:  2002-09       Impact factor: 10.057

10.  3-deoxy-3-[(18)F]fluorothymidine-positron emission tomography for noninvasive assessment of proliferation in pulmonary nodules.

Authors:  Andreas K Buck; Holger Schirrmeister; Martin Hetzel; Mareike Von Der Heide; Gisela Halter; Gerhard Glatting; Torsten Mattfeldt; Florian Liewald; Sven N Reske; Bernd Neumaier
Journal:  Cancer Res       Date:  2002-06-15       Impact factor: 12.701

View more
  38 in total

Review 1.  Visualizing cell death in experimental focal cerebral ischemia: promises, problems, and perspectives.

Authors:  Marietta Zille; Tracy D Farr; Ingo Przesdzing; Jochen Müller; Clemens Sommer; Ulrich Dirnagl; Andreas Wunder
Journal:  J Cereb Blood Flow Metab       Date:  2011-11-16       Impact factor: 6.200

2.  MRI stem cell tracking for therapy in experimental cerebral ischemia.

Authors:  Pedro Ramos-Cabrer; Mathias Hoehn
Journal:  Transl Stroke Res       Date:  2011-10-27       Impact factor: 6.829

3.  The Neural Cell Adhesion Molecule-Derived (NCAM)-Peptide FG Loop (FGL) Mobilizes Endogenous Neural Stem Cells and Promotes Endogenous Regenerative Capacity after Stroke.

Authors:  Rebecca Klein; Nicolas Mahlberg; Maurice Ohren; Anne Ladwig; Bernd Neumaier; Rudolf Graf; Mathias Hoehn; Morten Albrechtsen; Stephen Rees; Gereon Rudolf Fink; Maria Adele Rueger; Michael Schroeter
Journal:  J Neuroimmune Pharmacol       Date:  2016-06-28       Impact factor: 4.147

Review 4.  PET molecular imaging in stem cell therapy for neurological diseases.

Authors:  Jiachuan Wang; Mei Tian; Hong Zhang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-06-23       Impact factor: 9.236

Review 5.  In vivo imaging of endogenous neural stem cells in the adult brain.

Authors:  Maria Adele Rueger; Michael Schroeter
Journal:  World J Stem Cells       Date:  2015-01-26       Impact factor: 5.326

Review 6.  Genetic engineered molecular imaging probes for applications in cell therapy: emphasis on MRI approach.

Authors:  In K Cho; Silun Wang; Hui Mao; Anthony Ws Chan
Journal:  Am J Nucl Med Mol Imaging       Date:  2016-09-22

Review 7.  In vivo imaging for stem cell therapy: new developments and future challenges.

Authors:  Giovanni Lucignani; Martin Rodriguez-Porcel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-02       Impact factor: 9.236

8.  Noninvasive Evaluation of Cellular Proliferative Activity in Brain Neurogenic Regions in Rats under Depression and Treatment by Enhanced [18F]FLT-PET Imaging.

Authors:  Yasuhisa Tamura; Kayo Takahashi; Kumi Takata; Asami Eguchi; Masanori Yamato; Satoshi Kume; Masayuki Nakano; Yasuyoshi Watanabe; Yosky Kataoka
Journal:  J Neurosci       Date:  2016-08-03       Impact factor: 6.167

9.  The synthetic NCAM mimetic peptide FGL mobilizes neural stem cells in vitro and in vivo.

Authors:  Rebecca Klein; Stefan Blaschke; Bernd Neumaier; Heike Endepols; Rudolf Graf; Meike Keuters; Joerg Hucklenbroich; Morten Albrechtsen; Stephen Rees; Gereon Rudolf Fink; Michael Schroeter; Maria Adele Rueger
Journal:  Stem Cell Rev Rep       Date:  2014-08       Impact factor: 5.739

10.  Osteopontin Attenuates Secondary Neurodegeneration in the Thalamus after Experimental Stroke.

Authors:  Anne Ladwig; Rebecca Rogall; Jörg Hucklenbroich; Antje Willuweit; Michael Schoeneck; Karl-Josef Langen; Gereon R Fink; M Adele Rueger; Michael Schroeter
Journal:  J Neuroimmune Pharmacol       Date:  2018-11-28       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.